Company Description
Pharmacopeia has searched its libraries and found some promising compounds. The biotech drug discovery firm has moved from sifting through...
Key Pharmacopeia Financials
| Company Type | Public - NASDAQ (GM): PCOP Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $21.4 |
| 2006 Employees | 150 |
More Pharmacopeia Financials (11 pages)
Competition
Competitive Landscape for Biotechnology Sector
Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is...
Read more about Pharmacopeia's competition across multiple industries
Top Pharmacopeia Competitors
Sponsored Links
The Business Directory
Pharmacopeia Executives
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman and Interim CEO | Joseph A. Mollica | Network | E-mail |
| EVP, CFO, and Treasurer | Brian M. Posner | Network | E-mail |
| SVP Business Development | Simon M. Tomlinson | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Pharmacopeia News
- 8-HETEROARYLPURINE MNK2 INHIBITORS FOR TREATING METABOLIC DISORDERS [European Patents] (02 Dec 2008 08:23:00 EST)
- FUNCTIONALLY SELECTIVE ALPHA2C ADRENORECEPTOR AGONISTS [PCT Biblio Info] (11 Nov 2008 14:20:00 EST)
- NOVEL PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS [PCT Biblio Info] (05 Nov 2008 14:39:00 EST)
Sponsored Opportunity
